Regulation of Exocrine Pancreatic Progenitors by Ptf1a-p48
Ptf1a-p48 对外分泌胰腺祖细胞的调节
基本信息
- 批准号:7591123
- 负责人:
- 金额:$ 34.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-06-01 至 2013-03-31
- 项目状态:已结题
- 来源:
- 关键词:Acinar CellBHLH ProteinBiological AssayBiological ModelsCell CycleCell Differentiation processCellsCodeDataDefectDevelopmentDiabetes MellitusDifferentiation and GrowthDorsalElementsEpitheliumFunctional RNAGene ExpressionGene TargetingGenesGoalsGrowthIn VitroLaboratoriesLate EffectsLeadMalignant neoplasm of pancreasMediatingMicroRNAsMorphogenesisMusMutationNotch Signaling PathwayPancreasPancreatic BudPatternPhenotypePlayProcessRegulationReplacement TherapyResearchResourcesReverse Transcriptase Polymerase Chain ReactionRoleStagingStem cellsTestingTherapeuticUndifferentiatedWorkZebrafishbasecell growthdesigngain of functiongenome wide association studygenome-widehuman DICER1 proteinin vivoloss of functionmigrationmutantnovelpancreas developmentprogenitorprogramsprotein expressionpublic health relevanceresearch studytranscription factor
项目摘要
DESCRIPTION (provided by applicant): Pancreatic progenitor cells represent an important resource for cell replacement therapy in diabetes, and may also represent the cell-of-origin for pancreatic cancer. Among the many transcription factors regulating pancreatic development and differentiation, expression of the basic helix-loop-helix transcription factor, ptf1a-p48, represents the defining feature of pancreatic progenitor cells. Several laboratories, including our own, have identified distinct early and late effects of ptf1a-p48 during pancreatic development. Early in development, ptf1a-p48 is widely expressed in the emerging pancreatic epithelium, where it is required for specification of pancreatic identity, as well as for early growth and morphogenesis. Later in development, ptf1a-p48 becomes restricted to the exocrine compartment, where it induces cell cycle exit and acinar cell differentiation. However, the mechanisms by which ptf1a-p48 exerts its different developmental stage-specific effects remain unknown. We now propose to comprehensively characterize both early and late ptf1a-p48 functions, taking advantage of our unique ability to study pancreas development in both mouse and zebrafish. This work will be based on the following central hypotheses: First, that the early and late effects of ptf1a-p48 on pancreatic development are mediated through entirely different sets of ptf1a-p48 target genes; second, that different structural domains of the ptf1a-p48 molecule may be required for induction of these early and late effects; and third, that ptf1a-p48 target genes may include both coding and non-coding elements, including functionally important microRNA's. To test these hypotheses, the following Specific Aims will be pursued: 1) To identify discrete domains of the ptf1a-p48 molecule responsible for mediating its developmental stage-specific effects on pancreatic development, using newly developed in vivo assays; 2) To identify novel ptf1a-p48 target genes through genome-wide ChIP-on-chip analysis, and determine gain-of-function and loss-of-function phenotypes associated with altered expression of these genes; and 3) To identify and functionally characterize novel ptf1a-p48-regulated microRNA's in developing mouse and zebrafish pancreas. Together, these studies will determine the mechanisms by which ptf1a-p48 exerts its multiple influences in developing mouse and zebrafish pancreas. In so doing, it is likely that we will also identify important new regulators of pancreatic specification, morphogenesis and differentiation. By clarifying the role of this important transcription factor in regulating the pancreatic progenitor pool, these studies will contribute to the eventual therapeutic manipulation of these cells in the context of pancreatic cancer and diabetes.
Public Health Relevance: Pancreatic progenitor cells represent an important resource for cell replacement therapy in diabetes, and may also represent the cell-of-origin for pancreatic cancer. Studies in this proposal focus on how Ptf1a-p48, a pancreatic transcription factor, regulates the initial specification, growth and differentiation of pancreatic progenitor cells. We have recently completed two genome-wide screens for genes that may act downstream of Ptf1a-p48. In so doing, we have identified a number of additional coding and non-coding genes that may play important roles in regulating the pancreatic progenitor pool. Using both mouse and zebrafish model systems, we now plan to functionally characterize these novel Ptf1a-p48 target genes. By better clarifying how Ptf1a-p48 regulates progenitor cell growth and differentiation, these studies will contribute to the eventual therapeutic manipulation of pancreatic progenitors in the context of pancreatic cancer and diabetes.
描述(由申请人提供):胰腺祖细胞是糖尿病细胞替代疗法的重要来源,也可能是胰腺癌的起源细胞。在调节胰腺发育和分化的许多转录因子中,碱性螺旋-环-螺旋转录因子ptf 1a-p48的表达代表了胰腺祖细胞的定义特征。几个实验室,包括我们自己的实验室,已经确定了ptf 1a-p48在胰腺发育过程中不同的早期和晚期作用。在发育的早期,ptf 1a-p48在新生胰腺上皮中广泛表达,在那里它是胰腺特性的特化以及早期生长和形态发生所必需的。在发育后期,ptf 1a-p48被限制在外分泌区室,在那里它诱导细胞周期退出和腺泡细胞分化。然而,ptf 1a-p48发挥其不同发育阶段特异性作用的机制仍不清楚。我们现在建议全面表征ptf 1a-p48的早期和晚期功能,利用我们独特的能力来研究小鼠和斑马鱼的胰腺发育。这项工作将基于以下中心假设:第一,ptf 1a-p48对胰腺发育的早期和晚期效应是通过完全不同的ptf 1a-p48靶基因组介导的;第二,ptf 1a-p48分子的不同结构域可能需要诱导这些早期和晚期效应;第三,ptf 1a-p48靶基因可能包括编码和非编码元件,包括功能上重要的microRNA。为了验证这些假设,将追求以下具体目标:1)使用新开发的体内测定法来鉴定ptf 1a-p48分子的负责介导其对胰腺发育的发育阶段特异性作用的离散结构域; 2)通过全基因组ChIP-on-chip分析鉴定新的ptf 1a-p48靶基因,并确定与这些基因的表达改变相关的功能获得和功能丧失表型;和3)鉴定和功能表征发育中的小鼠和斑马鱼胰腺中的新型ptf 1a-p48调节的microRNA。总之,这些研究将确定ptf 1a-p48在小鼠和斑马鱼胰腺发育中发挥多重影响的机制。在这样做的过程中,我们很可能还将确定胰腺特化、形态发生和分化的重要新调节因子。通过阐明这种重要的转录因子在调节胰腺祖细胞库中的作用,这些研究将有助于在胰腺癌和糖尿病的背景下对这些细胞进行最终的治疗操作。
公共卫生相关性:胰腺祖细胞是糖尿病细胞替代疗法的重要来源,也可能是胰腺癌的起源细胞。本研究主要关注胰腺转录因子Ptf 1a-p48如何调控胰腺祖细胞的初始特化、生长和分化。我们最近完成了两个全基因组筛选可能作用于Ptf 1a-p48下游的基因。在这样做的过程中,我们已经确定了一些额外的编码和非编码基因,可能在调节胰腺祖细胞池中发挥重要作用。使用小鼠和斑马鱼模型系统,我们现在计划对这些新的Ptf 1a-p48靶基因进行功能表征。通过更好地阐明Ptf 1a-p48如何调节祖细胞的生长和分化,这些研究将有助于在胰腺癌和糖尿病的背景下对胰腺祖细胞的最终治疗操作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Steven D Leach其他文献
Steven D Leach的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Steven D Leach', 18)}}的其他基金
Developing ATAC-array as a novel epigenetic biomarker to guide personalized therapy in pancreatic cancer
开发 ATAC 阵列作为新型表观遗传生物标志物来指导胰腺癌的个性化治疗
- 批准号:
10512502 - 财政年份:2022
- 资助金额:
$ 34.34万 - 项目类别:
Administrative supplement for Early Drug Development Opportunity Program (EDDOP)
早期药物开发机会计划 (EDDOP) 的行政补充
- 批准号:
10677500 - 财政年份:2022
- 资助金额:
$ 34.34万 - 项目类别:
P30 Administrative Supplement to Cancer Center Support Grant to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators of the National Outreach Network.
P30 癌症中心支持补助金的行政补充,旨在通过国家外展网络的社区健康教育者加强 NCI 支持的社区外展能力。
- 批准号:
10370916 - 财政年份:2021
- 资助金额:
$ 34.34万 - 项目类别:
Community-led Action Research in Oncology: Pandemic-appropriate Radiotherapy Innovations Evaluated for LMICs
社区主导的肿瘤学行动研究:针对中低收入国家评估适合流行病的放射治疗创新
- 批准号:
10380931 - 财政年份:2021
- 资助金额:
$ 34.34万 - 项目类别:
Comprehensive genetic dissection of druggable KRAS targets
可药物 KRAS 靶点的全面基因剖析
- 批准号:
9476973 - 财政年份:2016
- 资助金额:
$ 34.34万 - 项目类别:
Comprehensive genetic dissection of druggable KRAS targets
可药物 KRAS 靶点的全面基因剖析
- 批准号:
9922888 - 财政年份:2016
- 资助金额:
$ 34.34万 - 项目类别:
Comprehensive genetic dissection of druggable KRAS targets
可药物 KRAS 靶点的全面基因剖析
- 批准号:
9080884 - 财政年份:2016
- 资助金额:
$ 34.34万 - 项目类别:
Functional Evaluation of Human Pancreatic Cancer Genes in a Zebrafish System
斑马鱼系统中人类胰腺癌基因的功能评估
- 批准号:
8464656 - 财政年份:2013
- 资助金额:
$ 34.34万 - 项目类别:
High resolution and single cell analyses of PanIN initiation and progression
PanIN 起始和进展的高分辨率单细胞分析
- 批准号:
8248212 - 财政年份:2011
- 资助金额:
$ 34.34万 - 项目类别:
High resolution and single cell analyses of PanIN initiation and progression
PanIN 起始和进展的高分辨率单细胞分析
- 批准号:
8095001 - 财政年份:2011
- 资助金额:
$ 34.34万 - 项目类别:
相似海外基金
The dual role of a bHLH protein: Is SCRM1 / ICE1 an integrator of cold-stress and stomatal fate signaling?
bHLH 蛋白的双重作用:SCRM1 / ICE1 是冷应激和气孔命运信号的整合者吗?
- 批准号:
179169260 - 财政年份:2010
- 资助金额:
$ 34.34万 - 项目类别:
Research Fellowships
RUI - Functional Characterization of a Nematode Gene Related to the Class II bHLH Protein, ABF-1
RUI - 与 II 类 bHLH 蛋白 ABF-1 相关的线虫基因的功能表征
- 批准号:
0111069 - 财政年份:2001
- 资助金额:
$ 34.34万 - 项目类别:
Continuing Grant
ROLE OF BHLH PROTEIN SCL IN HEMATOPOIETIC DEVELOPMENT
BHLH 蛋白 SCL 在造血发育中的作用
- 批准号:
6105666 - 财政年份:1998
- 资助金额:
$ 34.34万 - 项目类别:
ROLE OF BHLH PROTEIN SCL IN HEMATOPOIETIC DEVELOPMENT
BHLH 蛋白 SCL 在造血发育中的作用
- 批准号:
6239202 - 财政年份:1997
- 资助金额:
$ 34.34万 - 项目类别:
CASH: A NOVEL BHLH PROTEIN: ROLE IN GENE TRANSCRIPTION
CASH:一种新型 BHLH 蛋白质:在基因转录中的作用
- 批准号:
3088780 - 财政年份:1993
- 资助金额:
$ 34.34万 - 项目类别:
CASH--A NOVEL BHLH PROTEIN--ROLE IN GENE TRANSCRIPTION
CASH——一种新型 BHLH 蛋白质——在基因转录中的作用
- 批准号:
2259743 - 财政年份:1993
- 资助金额:
$ 34.34万 - 项目类别:
ROLE OF BHLH PROTEIN SCL IN HEMATOPOIETIC DEVELOPMENT
BHLH 蛋白 SCL 在造血发育中的作用
- 批准号:
2845061 - 财政年份:
- 资助金额:
$ 34.34万 - 项目类别:
ROLE OF BHLH PROTEIN SCL IN HEMATOPOIETIC DEVELOPMENT
BHLH 蛋白 SCL 在造血发育中的作用
- 批准号:
5210887 - 财政年份:
- 资助金额:
$ 34.34万 - 项目类别: